4
Changes in Ownership
RxSight, Inc. Filed Acc 0000950170-24-080522
Chief Financial Officer sold 18,402 shares at an average $58.68 ($1,079,816)
- Chief Financial Officer acquired 10,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Thunen Shelley B Chief Financial Officer | 2024-07-01 | Option exercise 10b5-1 | +10,000 | $15.60 | $155,983 | 23,938 | D: show line 1 in the form |
| Thunen Shelley B Chief Financial Officer | 2024-07-01 | Sale 10b5-1 | −8,146 | $58.41 | $475,785 | 15,792 | D: show line 2 in the form |
| Thunen Shelley B Chief Financial Officer | 2024-07-01 | Sale 10b5-1 | −1,854 | $59.48 | $110,270 | 13,938 | D: show line 3 in the form |
| Thunen Shelley B Chief Financial Officer | 2024-07-01 | Sale 10b5-1 | −6,599 | $58.55 | $386,366 | 1,803 | I: show line 4 in the form |
| Thunen Shelley B Chief Financial Officer | 2024-07-01 | Sale 10b5-1 | −1,803 | $59.56 | $107,394 | 0 | I: show line 5 in the form |
| Open-market sales · 18,402 sh · avg $58.68 · $1,079,816 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Thunen Shelley B Chief Financial Officer | 2024-07-01 | Option exercise · Stock Option (right to buy) 10b5-1 | −10,000 | 36,805 | D: show line 6 in the form |
Loading xslF345X05/ownership.xml…